๐ฐ Technologies Munich News
Page 2 - Technologies Munich News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technologies Munich. Real-time updates on events, politics, business and more.
October 24, 2023
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
October 24, 2023
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
October 24, 2023
CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.
October 19, 2023
Germany-based radiopharmaceutical biotech company ITM Isotope Technologies Munich SE and Canadian Nuclear Laboratories have launched Actineer, a joint venture for the industrial-scale production of actinium-225.
October 18, 2023
New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale...
October 18, 2023
GARCHING, Germany, MUNICH Germany and CHALK RIVER, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL),
October 18, 2023
New company will advance Actinium-225 technologies,ย quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotopeย
June 15, 2023
Garching / Munich, June 15, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a multidisciplinary symposium titled, “ Investing
June 13, 2023
New manufacturing plant in Neufahrn near Munich increases ITM's production capacity tenfoldCeremonial opening by Minister of State, Dr. Florian Herrmann,...
June 13, 2023
The new German facility has Industry 4.0 capabilities and will produce radionuclides to help meet the rising demand for radiopharmaceuticals.